Cardiorespiratory fitness and sex impact the colorectal cancer-suppressive effects of aerobic exercise serum

Technical Summary: Cardiorespiratory fitness and sex impact the colorectal cancer-suppressive effects of aerobic exercise serum

Problem Statement
While epidemiological evidence consistently links higher physical activity and cardiorespiratory fitness (CRF) to reduced colorectal cancer (CRC) risk, the specific biological mechanisms remain multifactorial. Previous in vitro studies have demonstrated that human serum collected after acute exercise can reduce the viability of various cancer cell lines. However, significant variability exists in these effects, and it remains unclear whether individual characteristics—specifically sex and baseline CRF—modulate the magnitude or presence of these anti-viability effects. Furthermore, the interplay between these non-modifiable (sex) and modifiable (CRF) factors in determining the therapeutic potential of exercise-conditioned serum has not been established.

Methodology
The study employed a randomized, controlled, counterbalanced crossover design involving 41 healthy participants (28 males, 13 females; aged 18–40). Participants were stratified into "high" and "low" CRF groups based on sex-specific $V̇O_2peak$ cut-offs (males: >45 vs. ≤45 ml·kg⁻¹·min⁻¹; females: >40 vs. ≤40 ml·kg⁻¹·min⁻¹).

Each participant completed two experimental trials separated by at least five days:

1. Exercise Trial: 30 minutes of moderate-intensity aerobic cycling at 65% $V̇O_2peak$.
2. Control Trial: 30 minutes of seated rest.

Serum samples were collected at three time points: pre-intervention (pre), immediately post-intervention (post0), and 60 minutes post-intervention (post60). These serum samples were used to treat the human colorectal cancer cell line Caco-2 for 48 hours. Cell viability was quantified using the MTT assay. The study utilized linear mixed-effects models (LMEMs) to analyze the effects of condition (exercise vs. control), time point, sex, and CRF on cell viability, treating participants as random intercepts.

Key Contributions
This study provides the first in vitro characterization of how individual participant characteristics (sex and CRF) modulate the anti-viability effects of acute exercise serum on colorectal cancer cells. It moves beyond generic exercise prescriptions by investigating whether the "exercise signal" in the blood is uniform across populations or dependent on specific physiological traits.

Results

• Baseline (Resting) Conditions: No significant differences in Caco-2 cell viability were observed between serum derived from males vs. females or high vs. low CRF groups when collected at rest.
• Acute Exercise Response (Overall): Across the entire cohort, exercise serum significantly reduced Caco-2 cell viability compared to control serum at both post0 and post60 time points.
• Modulation by CRF: The anti-viability effect was significantly modulated by CRF.
  • High CRF Group: Exercise serum significantly reduced cell viability at both post0 and post60 compared to control serum.
  • Low CRF Group: No statistically significant reduction in cell viability was observed between exercise and control serum at either time point.
• Modulation by Sex: The effect was also significantly modulated by sex.
  • Males: Exercise serum significantly reduced cell viability at both post0 and post60 compared to control serum.
  • Females: Exercise serum did not produce a statistically significant reduction in cell viability compared to control serum at either time point.

Significance and Claims
The authors claim that the anticancer potential of acute aerobic exercise serum is not universal but is contingent upon the physiological profile of the individual providing the serum. Specifically, the study suggests that:

1. Precision Exercise: The efficacy of exercise in creating a cancer-suppressive circulating milieu may require a threshold of cardiorespiratory fitness. Individuals with low CRF may not elicit the same magnitude of bioactive factors in their serum as those with high CRF following an acute bout of exercise.
2. Sex-Specific Responses: The therapeutic inhibitory effects of exercise serum on CRC cells observed in previous studies (often male-only cohorts) may not extrapolate to females, highlighting a need for sex-specific investigation in exercise oncology.
3. Mechanistic Insight: While the study does not identify the specific molecular mediators, it posits that the "collective exercise factor milieu" in high-CRF males is distinct and more potent in suppressing CRC cell viability than in low-CRF individuals or females.

The paper concludes that these findings support a shift toward "precision exercise" approaches, where exercise recommendations for CRC risk reduction may need to be tailored based on an individual's sex and fitness level to maximize potential benefits. The authors acknowledge limitations, including the use of a single male-derived cell line and a young, healthy population, suggesting that future research should explore these dynamics in older adults and using female-derived cell lines.